Teva: I Still See Upside After A Massive Rally (NYSE:TEVA)
· seekingalpha.com
Teva Pharmaceutical Industries is undergoing a strategic transformation, pivoting from generics to innovative biopharmaceuticals. Read more on TEVA here.
After years of following Teva Pharmaceutical Industries Limited ( TEVA ) and its decade of crisis, I believe the company is at its best period since 2015. It re...